Join the Pistoia Alliance for a 3-Part Webinar Series on Quantum Computing in the Pharmaceutical Industry
The Pistoia Alliance Quantum Computing Community of Interest is dedicated to exploring the rapidly evolving field of Quantum Computing and its transformative potential for the pharmaceutical industry. While Quantum Computing is still in its developmental stages, the promise it holds for revolutionizing pharma is immense. As stability in Quantum Computing technology is achieved, the opportunities for significant advancements in pharmaceutical research and development will soar.
In the current landscape, AI, ML, and generative AI dominate the spotlight, often overshadowing the advancements in Quantum Computing. This raises several pertinent questions: Does the rise of LLMs diminish the potential benefits of Quantum Computing for pharma? Can some tasks previously envisioned for Quantum Computing be handled by LLMs? How can the pharmaceutical industry integrate Quantum Computing into its problem-solving approaches? Moreover, does the industry possess the necessary skills to embrace this quantum revolution?
To address these crucial questions and more, the Pistoia Alliance is hosting a series of three webinars under the theme “Quantum Computing in Life Science R&D: Where Are We, Where Are We Going, When Will We Get There?”
Webinar #3: “When Will We Get There?”
Agenda
Webinar 3 will feature three lightning talks, sparking a dynamic discussion on the timeline to quantum advantage in life science R&D.
1: Technology Supply-Side Perspective:
• Gabriela Cimpan, Partner Manager, Quantinuum: Accelerating the Path to Universal, Fault-Tolerant Quantum Computing
2: Cross-Industry Perspective:
• Lene Oddershede, Senior Vice President, Professor, Novo Nordisk Foundation
3: Pharma Perspective:
• Robert Marino, CEO, Qubit Pharmaceuticals
Discussion – chaired by Brian Martin, Chief AI Product Owner, ACOS Senior Research Fellow, AbbVie
Don’t miss this opportunity to gain insights from leading experts and understand how Quantum Computing could shape the future of pharmaceutical research and development. Register now to secure your place in this groundbreaking series.